drugset / Trial / NCT04000139
Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis
Phase 2
Completed
48 enrolled
University of Zurich
Swiss National Science Foundation · collabThe Broad Foundation · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the efficacy and safety of a bilberry derived anthocyanin-rich extract in patients with ulcerative colitis. Two thirds of participants will receive the anthocyanin-rich extract, while one third will receive placebo, for 8 weeks of treatment.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2021-03-11
- Completion
- 2021-03-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | anthocyanin-rich extract | Unknown | 1000 mg | — |